| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 20.33B | 20.10B | 18.69B | 18.05B | 15.35B | 11.78B |
| Gross Profit | 6.02B | 5.78B | 4.47B | 4.22B | 4.69B | 3.60B |
| EBITDA | 5.09B | 4.81B | 3.42B | 2.01B | 3.21B | 2.24B |
| Net Income | -656.59M | -690.89M | -1.05B | 414.77M | 1.56B | 1.34B |
Balance Sheet | ||||||
| Total Assets | 42.28B | 43.66B | 46.20B | 43.45B | 31.96B | 22.20B |
| Cash, Cash Equivalents and Short-Term Investments | 1.17B | 882.37M | 3.94B | 2.86B | 1.02B | 2.62B |
| Total Debt | 26.82B | 26.49B | 28.08B | 23.32B | 13.18B | 10.21B |
| Total Liabilities | 30.34B | 31.50B | 33.10B | 28.70B | 17.08B | 13.14B |
| Stockholders Equity | 11.02B | 11.30B | 11.83B | 13.06B | 13.18B | 7.82B |
Cash Flow | ||||||
| Free Cash Flow | -404.95M | -651.89M | -3.66B | -6.13B | -5.53B | -2.06B |
| Operating Cash Flow | 5.36B | 5.84B | 4.39B | 2.55B | 2.27B | 1.71B |
| Investing Cash Flow | -4.42B | -5.60B | -4.34B | -10.78B | -8.70B | -4.75B |
| Financing Cash Flow | -935.49M | -3.11B | 2.99B | 8.05B | 5.42B | 5.09B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
72 Outperform | HK$1.57B | 1.96 | 10.09% | ― | 13.78% | 432.26% | |
62 Neutral | $20.33B | 14.63 | -3.31% | 3.23% | 1.93% | -12.26% | |
55 Neutral | HK$12.15B | -10.36 | -23.27% | 0.86% | -2.69% | -695.87% | |
54 Neutral | HK$18.44B | -42.17 | -3.91% | ― | 3.07% | -64.23% | |
53 Neutral | HK$2.85B | -7.07 | 0.82% | 0.69% | -7.11% | ― | |
48 Neutral | HK$10.72B | 17.54 | 15.66% | 1.33% | ― | ― |